An Open Label Study of Solifenacin Succinate (VESIcare®) for the Treatment of Overactive Bladder in Parkinson’s Disease, Israt Jahan, Camille Vaughan, Marian Evatt, Kelly Sullivan, Carlos Singer, Raul Ordorica, Theresa Zesiewicz
Kelly L. Sullivan

URGE-PD: A Multi-Site, Double-Blind, Randomized, Placebo-Controlled Trial of Solifenacin succinate (VESIcare®) for the Treatment of Overactive Bladder in Parkinson’s Disease, Theresa Zesiewicz, Marian Evatt, Israt Jahan, Camille Vaughan, Carlos Singer, Raul Ordorica, Kelly Sullivan
Kelly L. Sullivan

URGE-PD: A Multi-Site, Double-Blind, Randomized, Placebo-Controlled Trial of Solifenacin succinate (VESIcare®) for the Treatment of Overactive Bladder in Parkinson’s Disease, Theresa Zesiewicz, Marian Evatt, Israt Jahan, Camille Vaughan, Carlos Singer, Raul Ordorica, Kelly Sullivan
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

An Open Label Study of Solifenacin Succinate (VESIcare®) for the Treatment of Overactive Bladder in Parkinson’s Disease, Israt Jahan, Camille Vaughan, Marian Evatt, Kelly Sullivan, Carlos Singer, Raul Ordorica, Theresa Zesiewicz
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications